PRP remains the standard treatment for PDR, but it may lead to permanent peripheral visual field loss, reduced night vision, or worsen existing DME, increasing its occurrence [37]
Tracking progress in a journal can help
and the conversion of 5-methyltetrahydrofolate to tetrahydrofolate
Ingredients: Dimethicone, Cetearyl Olivate, Sorbitan Olivate, Water, Methyl Trimethicone, Potassium Cetyl Phosphate, Sorbitan Stearate, Polyglyceryl-10 Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, Glutathione, 2-O-Ethyl Ascorbic Acid, Ethylhexylglycerin, Lavandula Angustifolia Oil, Caprylyl Glycol, Adenosine, Xanthium Strumarium Fruit Extract, Butylene Glycol, Ceramide EOP, Fragrance, Linalool, Limonene